BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31621625)

  • 1. Sex differences in the short-term and long-term effects of subthalamic nucleus stimulation in Parkinson's disease.
    Kim R; Yoo D; Choi JH; Shin JH; Park S; Kim HJ; Paek SH; Jeon B
    Parkinsonism Relat Disord; 2019 Nov; 68():73-78. PubMed ID: 31621625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
    Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ
    J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of subthalamic nucleus deep brain stimulation on freezing of gait in Parkinson's disease.
    Kim R; Kim HJ; Shin C; Park H; Kim A; Paek SH; Jeon B
    J Neurosurg; 2019 Jan; 131(6):1797-1804. PubMed ID: 30641837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The probable REM sleep behavior disorder negatively affects health-related quality of life in Parkinson's disease with bilateral subthalamic nucleus stimulation.
    Park S; Kim R; Shin JH; Kim HJ; Paek SH; Jeon B
    Parkinsonism Relat Disord; 2020 Dec; 81():136-139. PubMed ID: 33129010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in quality of life following subthalamic stimulation for Parkinson's disease.
    Hariz GM; Limousin P; Zrinzo L; Tripoliti E; Aviles-Olmos I; Jahanshahi M; Hamberg K; Foltynie T
    Acta Neurol Scand; 2013 Oct; 128(4):281-5. PubMed ID: 23550919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of bilateral subthalamic nucleus stimulation in Chinese Parkinson's disease patients.
    Li J; Zhang Y; Li Y
    Br J Neurosurg; 2015 Jun; 29(3):329-33. PubMed ID: 25812021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of Daily Living and Their Relationship to Health-Related Quality of Life in Patients with Parkinson Disease After Subthalamic Nucleus Deep Brain Stimulation.
    Gorecka-Mazur A; Furgala A; Krygowska-Wajs A; Pietraszko W; Kwinta B; Gil K
    World Neurosurg; 2019 May; 125():e552-e562. PubMed ID: 30716489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson's disease.
    Choi JH; Kim HJ; Lee JY; Yoo D; Im JH; Paek SH; Jeon B
    PLoS One; 2019; 14(8):e0221219. PubMed ID: 31454366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.
    Drapier S; Raoul S; Drapier D; Leray E; Lallement F; Rivier I; Sauleau P; Lajat Y; Edan G; Vérin M
    J Neurol; 2005 May; 252(5):583-8. PubMed ID: 15778909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease.
    Dafsari HS; Ray-Chaudhuri K; Ashkan K; Sachse L; Mahlstedt P; Silverdale M; Rizos A; Strack M; Jost ST; Reker P; Samuel M; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Timmermann L;
    J Neurol; 2020 Jun; 267(6):1830-1841. PubMed ID: 32152689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of bilateral STN-DBS on non-motor symptoms in Parkinson's disease: A four-year observational, prospective study.
    Georgiev D; Mencinger M; Rajnar R; Mušič P; Benedičič M; Flisar D; Bošnjak R; Mehrkens J; Pirtošek Z; Boetzel K; Trošt M
    Parkinsonism Relat Disord; 2021 Aug; 89():13-16. PubMed ID: 34216935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
    Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
    Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?
    Merola A; Rizzi L; Zibetti M; Artusi CA; Montanaro E; Angrisano S; Lanotte M; Rizzone MG; Lopiano L
    J Neurol Neurosurg Psychiatry; 2014 May; 85(5):552-9. PubMed ID: 23847290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease patients over 75 years of age.
    Sharma VD; Lyons KE; Nazzaro JM; Pahwa R
    J Neurol Sci; 2019 Apr; 399():57-60. PubMed ID: 30772762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.
    Mossner JM; Patil PG; Chou KL
    J Neural Transm (Vienna); 2019 Nov; 126(11):1479-1483. PubMed ID: 31494731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.